Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Decitabine × Clear all

NCT01194908 2015-01-26

Re-expression of ER in Triple Negative Breast Cancers

Phase 1/2 Terminated

5 enrolled 5 charts

Breast Neoplasms